1. Your patient with type 2 diabetes has been on metformin for 6 months. His A1c is 7.8%. What would you recommend?

2. What is the ADA-recommended starting dose of basal insulin?

3. What is the approximate half-life of the two available (U-300 and U-200) concentrated basal insulins?

4. Your patient and you have agreed to switch from 15 units insulin glargine U-100 to insulin glargine U-300. Which of the following is the most correct conversion to U-300?

5. Which of the following is most correct about insulin stacking with long-acting basal insulin use?

6. Which of the following characteristics of concentrated basal insulin is FALSE?

7. Which of the following is most correct about patient adherence to diabetes regimens?

8. Your patient has type 2 diabetes and was stented 2 years ago. Medications are metformin ER 500 mg twice daily with meals, glimepiride 4 mg daily, atorvastatin 80 mg daily, sitagliptin 100 mg daily, aspirin 81 mg daily, lisinopril 40 mg daily, clopidogrel 75 mg daily. She was to start on basal insulin at 10 units but failed to do so. Over the last 2 months, she has been checking and documenting her fasting capillary glucose about 3 times a week: What is the most likely reason she did not start insulin? View Chart

9. Which of the following statements is FALSE about the comparison of a GLP-1 receptor agonist and basal insulin combination with a basal-bolus combination?

10. Your patient is injecting degludec 58 units every AM, as this is the most convenient time for her. But, sometimes she forgets to take it and remembers in the evening. What should you tell her to do?

« Return to Activity